Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy

The purpose of this research was to study the influence of cardiac resynchronisation therapy (CRT) in combination with other interventional techniques used during one hospital stay on systemic inflammation and neurohumoral status in patients with ischemic cardiomyopathy (ICMP). The best response to...

Full description

Bibliographic Details
Main Authors: В. А. Кузнецов, Т. Н. Енина, П. В. Шебеко, А. Ю. Рычков, Т. И. Петелина, Н. Н. Мельников, Т. О. Виноградова
Format: Article
Language:English
Published: Meshalkin National Medical Research Center 2015-10-01
Series:Патология кровообращения и кардиохирургия
Subjects:
Online Access:http://journalmeshalkin.ru/index.php/heartjournal/article/view/26
_version_ 1827844402343575552
author В. А. Кузнецов
Т. Н. Енина
П. В. Шебеко
А. Ю. Рычков
Т. И. Петелина
Н. Н. Мельников
Т. О. Виноградова
author_facet В. А. Кузнецов
Т. Н. Енина
П. В. Шебеко
А. Ю. Рычков
Т. И. Петелина
Н. Н. Мельников
Т. О. Виноградова
author_sort В. А. Кузнецов
collection DOAJ
description The purpose of this research was to study the influence of cardiac resynchronisation therapy (CRT) in combination with other interventional techniques used during one hospital stay on systemic inflammation and neurohumoral status in patients with ischemic cardiomyopathy (ICMP). The best response to CRT was estimated in 59 patients with ICMP (mean age 588.3 years, 92% males).The patients were divided into 2 groups: Group I patients (n=48) included those with 'pure' CRT, while Group II patients (n=11) underwent CRT, coronary stenting (CS), radiofrequency atrioventricular node ablation (RFA). All interventions were performed during one hospital stay. There were no significant differences in demographic characteristics between the groups. Mean follow-up was 6.0 [2.0; 16.0] months. Plasma levels of Nt-proBNP, interleukin (IL)-1, IL-6, IL-10, tumor necrosis factor-alpha (TNF-), C-reactive protein (CRP), urinary levels of epinephrine and norepinephrine (NE) were measured. The patients with a decrease in left ventricular end-systolic volume 15% were classified as responders. There were no significant differences in responders between the groups and was equal to 32 (67%) and 9 (82%) respectively. At baseline the plasma levels of IL-6 and CRP were higher in Group II as compared with Group I: 9.3 [4.6; 14.8] vs 3.3 [1.9; 5.2] pg/ml, respectively (p=0.004) and 8.0 [6.0; 10.2] vs 3.2 [1.5; 5.1] mg/ml respectively (p=0.065). At baseline the urinary NE level was lower in Group II as compared with Group I: 30.0 [17.6; 34.4] vs 58.0 [38.5; 74.6] nmol/ml respectively (p=0.023). During follow-up in Group I only Nt-proBNP level (p=0.015) tended to decrease. In Group II the levels of IL-6 (p=0.038), TNF- (p=0.024), CRP (p=0.031) decreased and NE level increased (p=0.038). Thus, the combination of CRT with other interventions is associated with a decrease in systemic inflammation and an impact on the neurohumoral status of patients with ICMP as compared with 'pure' CRT.
first_indexed 2024-03-12T08:41:18Z
format Article
id doaj.art-ddc411ecbf1d46268bfa47d5fbdf2fa6
institution Directory Open Access Journal
issn 1681-3472
2500-3119
language English
last_indexed 2024-03-12T08:41:18Z
publishDate 2015-10-01
publisher Meshalkin National Medical Research Center
record_format Article
series Патология кровообращения и кардиохирургия
spelling doaj.art-ddc411ecbf1d46268bfa47d5fbdf2fa62023-09-02T16:48:43ZengMeshalkin National Medical Research CenterПатология кровообращения и кардиохирургия1681-34722500-31192015-10-0118415115710.21688/1681-3472-2014-4-151-157746Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathyВ. А. КузнецовТ. Н. ЕнинаП. В. ШебекоА. Ю. РычковТ. И. ПетелинаН. Н. МельниковТ. О. ВиноградоваThe purpose of this research was to study the influence of cardiac resynchronisation therapy (CRT) in combination with other interventional techniques used during one hospital stay on systemic inflammation and neurohumoral status in patients with ischemic cardiomyopathy (ICMP). The best response to CRT was estimated in 59 patients with ICMP (mean age 588.3 years, 92% males).The patients were divided into 2 groups: Group I patients (n=48) included those with 'pure' CRT, while Group II patients (n=11) underwent CRT, coronary stenting (CS), radiofrequency atrioventricular node ablation (RFA). All interventions were performed during one hospital stay. There were no significant differences in demographic characteristics between the groups. Mean follow-up was 6.0 [2.0; 16.0] months. Plasma levels of Nt-proBNP, interleukin (IL)-1, IL-6, IL-10, tumor necrosis factor-alpha (TNF-), C-reactive protein (CRP), urinary levels of epinephrine and norepinephrine (NE) were measured. The patients with a decrease in left ventricular end-systolic volume 15% were classified as responders. There were no significant differences in responders between the groups and was equal to 32 (67%) and 9 (82%) respectively. At baseline the plasma levels of IL-6 and CRP were higher in Group II as compared with Group I: 9.3 [4.6; 14.8] vs 3.3 [1.9; 5.2] pg/ml, respectively (p=0.004) and 8.0 [6.0; 10.2] vs 3.2 [1.5; 5.1] mg/ml respectively (p=0.065). At baseline the urinary NE level was lower in Group II as compared with Group I: 30.0 [17.6; 34.4] vs 58.0 [38.5; 74.6] nmol/ml respectively (p=0.023). During follow-up in Group I only Nt-proBNP level (p=0.015) tended to decrease. In Group II the levels of IL-6 (p=0.038), TNF- (p=0.024), CRP (p=0.031) decreased and NE level increased (p=0.038). Thus, the combination of CRT with other interventions is associated with a decrease in systemic inflammation and an impact on the neurohumoral status of patients with ICMP as compared with 'pure' CRT.http://journalmeshalkin.ru/index.php/heartjournal/article/view/26ИШЕМИЧЕСКАЯ КАРДИОМИОПАТИЯФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙКАРДИОРЕСИНХРОНИЗИРУЮЩАЯ ТЕРАПИЯСИСТЕМНОЕ ВОСПАЛЕНИЕНЕЙРОГУМОРАЛЬНАЯ РЕГУЛЯЦИЯ
spellingShingle В. А. Кузнецов
Т. Н. Енина
П. В. Шебеко
А. Ю. Рычков
Т. И. Петелина
Н. Н. Мельников
Т. О. Виноградова
Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy
Патология кровообращения и кардиохирургия
ИШЕМИЧЕСКАЯ КАРДИОМИОПАТИЯ
ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ
КАРДИОРЕСИНХРОНИЗИРУЮЩАЯ ТЕРАПИЯ
СИСТЕМНОЕ ВОСПАЛЕНИЕ
НЕЙРОГУМОРАЛЬНАЯ РЕГУЛЯЦИЯ
title Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy
title_full Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy
title_fullStr Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy
title_full_unstemmed Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy
title_short Influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro-immuno-humoral status of patients with ischemic cardiomyopathy
title_sort influence of cardiac resynchronisation therapy combined with other interventional methods on the neuro immuno humoral status of patients with ischemic cardiomyopathy
topic ИШЕМИЧЕСКАЯ КАРДИОМИОПАТИЯ
ФИБРИЛЛЯЦИЯ ПРЕДСЕРДИЙ
КАРДИОРЕСИНХРОНИЗИРУЮЩАЯ ТЕРАПИЯ
СИСТЕМНОЕ ВОСПАЛЕНИЕ
НЕЙРОГУМОРАЛЬНАЯ РЕГУЛЯЦИЯ
url http://journalmeshalkin.ru/index.php/heartjournal/article/view/26
work_keys_str_mv AT vakuznecov influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy
AT tnenina influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy
AT pvšebeko influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy
AT aûryčkov influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy
AT tipetelina influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy
AT nnmelʹnikov influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy
AT tovinogradova influenceofcardiacresynchronisationtherapycombinedwithotherinterventionalmethodsontheneuroimmunohumoralstatusofpatientswithischemiccardiomyopathy